This memo conveys supporting fact sheets for use in informing DoD Firefighters and Occupational Medicine (OM) providers involved in implementing the NDAA 2020, which allows for blood testing, beginning October 1, 2020, to determine and document potential exposure to PFAS during their annual physicals.

Use this template to provide the de-identification process to be used for your project. The plan should show how MHS sensitive data elements (or quasi-identifiers) will be de-identified as well as how the 18 HIPAA identifiers will be handled (e.g., dropped, collapsed, etc.).

Overview of the digital health resources and tools available from the Defense Health Agency supporting provider resilience.

As part of the Joint HIE, the Military Health System (MHS) has joined national efforts to safely and securely share your health care information electronically with participating eHealth Exchange* providers from which you may receive care.

The Military Health System has joined national efforts to safely and securely share your health care information electronically through the Joint Health Information Exchange (jHIE) with other organizations from where you may receive care.

Patients can fill out this form to opt back into using the Joint HIE.

Through partnership with the eHealth Exchange, the Military Health System (MHS) Joint Health Information Exchange (jHIE) joined national efforts to securely share MHS beneficiary health care information electronically with other federal and private sector partners from which MHS patients may receive health care.

Customize this publication with your facility's information and hand it out to patients who visit.

Patients will submit this letter when they want to opt out of using the Joint HIE.

The DoD, in selecting potential candidates for the Panel, reviews the educational and professional credentials of individuals and bases its selection on this review and the subject matters being handled by the Panel.

This charter describes the Uniform Formulary Beneficiary Advisory Panel and it responsibilities

This clinical recommendation provides background of pre-deployment neurocognitive testing and the use of automated neuropsychological assessment metrics (ANAM).

This clinical recommendation serves as a reference tool offering medical guidance following indications from post-injury neuroendocrine screening.

The PHQ-9 is a nine-item tool commonly used in the primary care setting to assess the presence and severity of depression symptoms.

This document acknowledges those who participated in the expert working group and provides the resources used to update the Management of Sleep Disturbances following Concussion/Mild TBI: Guidance for Primary Care Management in Deployed and Non-Deployed Settings clinical recommendation.